These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 14677698)

  • 1. Factors to consider when using vaccine to control an exotic disease outbreak.
    DeHaven WR
    Dev Biol (Basel); 2003; 114():281-9. PubMed ID: 14677698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and opportunities in developing and marketing vaccines for OIE List A and emerging animal diseases.
    Gay CG; Salt J; Balaski C
    Dev Biol (Basel); 2003; 114():243-50. PubMed ID: 14677694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory considerations for emergency use of non-USDA licensed vaccines in the United States.
    Hill RE; Foley PL; Carr MY; Elsken LA; Gatewood DM; Ludemann LR; Wilbur LA
    Dev Biol (Basel); 2003; 114():31-52. PubMed ID: 14677675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of management practices for the control of anthrax in animals: the 2005 anthrax epizootic in North Dakota--case study.
    Ndiva Mongoh M; Dyer NW; Stoltenow CL; Hearne R; Khaitsa ML
    Zoonoses Public Health; 2008 Aug; 55(6):279-90. PubMed ID: 18489538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulations for vaccines against emerging infections and agrobioterrorism in the United States of America.
    Elsken LA; Carr MY; Frana TS; Brake DA; Garland T; Smith K; Foley PL
    Rev Sci Tech; 2007 Aug; 26(2):429-41. PubMed ID: 17892163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control and eradication of O.I.E. list A diseases--the approach of the European Union to the use of vaccines.
    Laddomada A
    Dev Biol (Basel); 2003; 114():269-80. PubMed ID: 14677697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory considerations for emergency use of vaccines in the European Union.
    Pastoret PP; Mackay D
    Dev Biol (Basel); 2003; 114():53-8. PubMed ID: 14677676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
    Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
    Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory considerations for marker vaccines and diagnostic tests in the U.S.
    Foley PL; Hill RE
    Biologicals; 2005 Dec; 33(4):253-6. PubMed ID: 16257538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The North American Animal Disease Spread Model: a simulation model to assist decision making in evaluating animal disease incursions.
    Harvey N; Reeves A; Schoenbaum MA; Zagmutt-Vergara FJ; Dubé C; Hill AE; Corso BA; McNab WB; Cartwright CI; Salman MD
    Prev Vet Med; 2007 Dec; 82(3-4):176-97. PubMed ID: 17614148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DNA vaccines for veterinary medicine].
    Gerdts V; Mettenleiter TC
    Dtsch Tierarztl Wochenschr; 2001 Jan; 108(1):3-10. PubMed ID: 11232422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Australian contingency plans for emergency animal disease control: the role of antigen/vaccine banks.
    Tweddle NE
    Dev Biol (Basel); 2004; 119():295-306. PubMed ID: 15742641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USDA seeking veterinarians' help in promoting NAIS. Nationwide identification system to be used for disease, contamination control.
    Cima G
    J Am Vet Med Assoc; 2009 Jan; 234(2):178-80. PubMed ID: 19210234
    [No Abstract]   [Full Text] [Related]  

  • 14. A work in progress. Agriculture stakeholders discuss national ID plan.
    Nolen RS
    J Am Vet Med Assoc; 2004 Aug; 225(3):345-6. PubMed ID: 15328708
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulatory requirements for vaccine authorisation.
    Jones PG; Cowan G; Gravendyck M; Nagata T; Robinson S; Waits M
    Rev Sci Tech; 2007 Aug; 26(2):379-93. PubMed ID: 17892159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines and animal welfare.
    Morton DB
    Rev Sci Tech; 2007 Apr; 26(1):157-63. PubMed ID: 17633300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastle disease outbreak.
    Kapczynski DR; King DJ
    Vaccine; 2005 May; 23(26):3424-33. PubMed ID: 15837366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral vaccination of wildlife against rabies: opportunities and challenges in prevention and control.
    Rupprecht CE; Hanlon CA; Slate D
    Dev Biol (Basel); 2004; 119():173-84. PubMed ID: 15742629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in biosecurity to 2010 and beyond: towards integrated detection, analysis and response to exotic pest invasions.
    French NP; Gemmell NJ; Buddle BM
    N Z Vet J; 2007 Dec; 55(6):255-63. PubMed ID: 18059642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.